NVFY     got the shift, now this is a short if it breaks the 3.35 area

CANN    another short if it breaks 2.20, will be careful for squeezes

BLDP* this is trying to break 2.50 but failed on the close and morning spike

SCYX      up on analyst upgrade price target of $16

CRPX      analyst upgrade pushed this up, potential short if this cracks 1.30, has not held its gains in the past

AUPH    this is gaped up a dollar before the market opened today, up on drug PR and now an increase remission rate for treatment announcement AND positive results from study

CRMD   other traders expect this could keep running tomorrow, (not sure what this will do but post-market looks good for a morning spike) definitely failed in the morning and just faded the rest of the day. Not enough volume for a trade now. But will keep on watch.

ABEO     nice breakout but didn’t completely hold its gains, this was a dud today and not enough volume as of now has a nice catalyst with approval of second clinical trials for a syndrome

CRBP     this had a nice breakout of recent highs with a good catalyst, held support @ 8.40 but has resistance @ 9.8. failed morning spike, this double topped so it could be finally getting weak

GNK       this company spammed an announcement for a couple days and now is selling a bunch of shares at a now discounted price, this is a short for tomorrow. Plus the long term chart suggests that it can’t hold its gains

NEPT     broke long term resistance but has lots of overhead res still and has history of not holding its gains, up on a patent agreement